Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ryotaro Nakai"'
Publikováno v:
Microsystems & Nanoengineering, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Implementing a signal-switching mechanism for the selective use of integrated sensors and actuators plays a crucial role in streamlining the functionality of miniaturized devices. Here, a liquid metal droplet (LMD)-based signal-switching mec
Externí odkaz:
https://doaj.org/article/0994444c6efd4916a52ea24d77b560b1
Autor:
Tomoki Nishikawa, Juria Kitabayashi, Takehiro Hayashi, Fanwei Liu, Masaya Funaki, Ryotaro Nakai, Kazuhisa Murai, Taro Yamashita, Masao Honda, Shuichi Kaneko, Takayoshi Shirasaki, Tetsuro Shimakami, Hitoshi Omura, Ariunaa Sumiyadorj
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Hepatitis C virus (HCV) cell culture systems have facilitated the development of efficient direct-acting antivirals against HCV. Huh-7.5, a subline of the human hepatoma cell line Huh-7, has been used widely to amplify HCV because HCV can efficiently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::554c5f734bed3787c5f13a355c41335f
http://europepmc.org/articles/PMC6538753
http://europepmc.org/articles/PMC6538753
Autor:
Masaki Miyazawa, Jun Seishima, Ryotaro Nakai, Takuya Komura, Hiroyuki Furukawa, Atsuhiro Kawashima, Hajime Ota, Takashi Kagaya, Masashi Unoura, Youhei Marukawa
Publikováno v:
Kanzo. 57:320-327
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0d8b0607d7b7df2934a55573a2cdc6c
https://doi.org/10.2957/kanzo.57.320
https://doi.org/10.2957/kanzo.57.320
Autor:
Masatoshi Yamato, Yohei Marukawa, Takashi Kagaya, Ryotaro Nakai, Kiichiro Kaji, Kiyoki Kitagawa, Takuya Komura, Hajime Ohta, Masashi Unoura, Shuichi Kaneko, Atsuhiro Kawashima, Jun Seishima, Masaki Miyazawa
Publikováno v:
Internal Medicine. 55:1923-1927
Tocilizumab, an anti-human interleukin 6 receptor (IL-6R) monoclonal antibody, is widely used to treat rheumatoid arthritis (RA) and is expected to exhibit clinical efficacy when used to treat other autoimmune diseases. However, a risk of opportunist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::952eda3d3ee3ea07ff231b351e019c8b
https://doi.org/10.2169/internalmedicine.55.5981
https://doi.org/10.2169/internalmedicine.55.5981
Autor:
Yoshiaki, Shimizu, Takuya, Komura, Takuya, Seike, Ryotaro, Nakai, Hitoshi, Omura, Takashi, Kagaya, Hajime, Ohta, Satomi, Kasashima, Atsuhiro, Kawashima, Masashi, Unoura
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 114(7)
Recently, morbidities due to primary cytomegalovirus (CMV) infection have increased in young Japanese adults because of decreased anti-CMV antibodies in them. CMV infections are typically resolved naturally in immunocompetent individuals, and complic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6ccf9822e8e5550d22a7fdc0ff6aab63
https://pubmed.ncbi.nlm.nih.gov/28679983
https://pubmed.ncbi.nlm.nih.gov/28679983
Autor:
Takuya, Seike, Takashi, Kagaya, Takuya, Komura, Ryotaro, Nakai, Yoshiaki, Shimizu, Hitoshi, Omura, Hajime, Ohta, Shigekazu, Ohyama, Atsuhiro, Kawashima, Masashi, Unoura
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 114(6)
A 40-year-old man complaining of abdominal distention was referred to our hospital. Computed tomography of the abdomen demonstrated a very large abdominal mass with fat and calcification. The size of the mass rapidly increased from 30cm to 40cm over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f506eaf52eb1ff7761d18c2a1861a7ee
https://pubmed.ncbi.nlm.nih.gov/28579584
https://pubmed.ncbi.nlm.nih.gov/28579584
Autor:
Masaki Nishitani, Naoki Ooishi, Hidenori Kido, Haruhiko Shugo, Hisashi Takabatake, Yoshiko Takata, Ryotaro Nakai, Eishiro Mizukoshi, Hikaru Hayakawa, Hideki Mizuno, Noriaki Orita, Hajime Sunagozaka, Takeshi Terashima, Kotaro Hayashi, Tatsuya Yamashita, Hitoshi Omura, Kazuki Nagai, Yoshimoto Nomura, Masataka Kanno, Shuichi Kaneko
Publikováno v:
Journal of Clinical Oncology. 37:407-407
407 Background: Several new combination therapies, including GEM plus nab-paclitaxel (GnP) and FOLFIRINOX (FFX) has been developed for treating pancreatic ductal adenocarcinoma (PDAC) in these ten years. We investigated trends in characteristics, tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc60d46368d89ae79a33e87c14ef2edc
https://doi.org/10.1200/jco.2019.37.4_suppl.407
https://doi.org/10.1200/jco.2019.37.4_suppl.407